Loracarbef is a new orally active, broad-spectrum cephalosporin suitable for twice a
day dosing. It is approved for use in both adults and children for the treatment of upper
and lower respiratory tract infections, urinary tract and skin infections.
Melting point 205～215℃ (decomposition). [α]D21+34.0°(C=0.35, water).
LORACARBEF's antibacterial activity is similar to that of cefaclor and cefuroxime aspirin, and it is used for pneumonia, pharyngitis, chronic bronchitis, secondary bacterial infections of mild to moderate acute bronchitis, tonsillitis, etc. caused by susceptible bacteria.
ChEBI: The monohydrated form of loracarbef.
